Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Mental Health Medication Recalls

Recalls of antidepressants, anti-anxiety and related psychiatric medications.

224 recalls in this category, newest first.

Class II · Moderate risk

buPROPion HCl ER

Labeling:Label Mixup; buPROPion HCl ER (XL), Tablet, 150 mg may be potentially mislabeled as MESALAMINE CR, Capsule, 250 mg, NDC 54092018981, Pedigree: AD52412_1, EXP: 5/17/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-722-2014
Class II · Moderate risk

QUEtiapine FUMARATE

Labeling:Label Mixup; QUEtiapine FUMARATE, Tablet, 25 mg may be potentially mislabeled as chlordiazePOXIDE HCl, Capsule, 25 mg, NDC 00555015902, Pedigree: AD49426_1, EXP: 5/16/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-716-2014
Class II · Moderate risk

QUEtiapine FUMARATE Tablet

Labeling:Label Mixup; QUEtiapine FUMARATE Tablet, 100 mg may be potentially mislabeled as DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: W002776, EXP: 6/6/2014; NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 37205098769, Pedigree: W003823, EXP: 6/27/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD60578_5, EXP: 5/29/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-665-2014
Class II · Moderate risk

QUEtiapine FUMARATE

Labeling:Label Mixup; QUEtiapine FUMARATE, Tablet, 25 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Chew Tablet, NDC 58914001460, Pedigree: AD32325_1, EXP: 5/9/2014; ASPIRIN DR EC, Tablet, 81 mg, NDC 00182106105, Pedigree: W003094, EXP: 6/13/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-664-2014
Class II · Moderate risk

CITALOPRAM Tablet

Labeling:Label Mixup; CITALOPRAM Tablet, 10 mg may be potentially mislabeled as OXYBUTYNIN CHLORIDE, Tablet, 5 mg, NDC 00603497521, Pedigree: AD52778_61, EXP: 5/20/2014; COENZYME Q-10, Capsule, 30 mg, NDC 00904501546, Pedigree: W002814, EXP: 6/7/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-630-2014
Class II · Moderate risk

QUETIAPINE FUMARATE Tablet

Labeling: Label Mixup; QUETIAPINE FUMARATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as SIMVASTATIN, Tablet, 40 mg, NDC 00093715598, Pedigree: AD22845_4, EXP: 5/2/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-575-2014
Class II · Moderate risk

buPROPion HCl ER Tablet

Labeling: Label Mixup; buPROPion HCl ER Tablet, 200 mg may be potentially mislabeled as AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: W002726, EXP: 6/6/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-573-2014
Class II · Moderate risk

VENLAFAXINE HCL Tablet

Labeling: Label Mixup; VENLAFAXINE HCL Tablet, 50 mg may be potentially mislabeled as sulfaSALAzine, Tablet, 500 mg, NDC 00603580121, Pedigree: AD65475_19, EXP: 5/28/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-534-2014
Class II · Moderate risk

SERTRALINE HCL Tablet

Labeling: Label Mixup; SERTRALINE HCL Tablet, 50 mg may be potentially mislabeled as NORTRIPTYLINE HCL, Capsule, 10 mg, NDC 00093081001, Pedigree: AD70585_4, EXP: 5/29/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003574, EXP: 6/24/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD46300_17, EXP: 5/15/2014; CHOLECALCIFEROL, Tablet,

Terminated Labeling / mix-up Aidapak Services, LLC D-523-2014
Class II · Moderate risk

FLUoxetine HCl Capsule

Labeling: Label Mixup; FLUoxetine HCl, Capsule, 10 mg may be potentially mislabeled as PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, NDC 00032122401, Pedigree: AD70585_10, EXP: 5/29/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-517-2014
Class II · Moderate risk

VENLAFAXINE Tablet

Labeling: Label Mixup; VENLAFAXINE Tablet, 25 mg may be potentially mislabeled as OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD65457_22, EXP: 5/24/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-516-2014
Class II · Moderate risk

Venlafaxine Hydrochloride Tablets

Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.

Terminated Failed specification Zydus Pharmaceuticals USA Inc NDC 68382-021-01 D-202-2013
Class II · Moderate risk

QUETIAPINE Fumarate Tablets 25mg 100 Tablets

Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

Terminated Dissolution failure American Health Packaging NDC 68084-530-01 D-802-2013
Class II · Moderate risk

Dr. Reddy's Quetiapine Fumarate Tablets

Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 55111-249-05 D-059-2013
Class III · Low risk

Venlafaxine ER 150mg

Labeling: Label Mix-up: Product was incorrectly labeled,"Tabs" instead of "Capsules."

Terminated Labeling / mix-up Stat Rx USA NDC 42549-684-30 D-051-2013
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-344-30 D-180-2013
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-343-30 D-179-2013
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-342-30 D-178-2013